Advertisement

Advertisement

Lynn Sage Breast Cancer Symposium 2024

By The ASCO Post Staff / Lynn Sage Breast Cancer Symposium 2024

Charles E. Geyer, Jr., MD, FACP, on Management of the Patient With HER2+ Breast Cancer in 2024

Charles E. Geyer, Jr., MD, FACP, discusses the management of patients with HER2+ breast cancer in 2024, based in part on his presentation at the Lynn Sage Breast Cancer Symposium, October 2024. Dr. Ge...

By The ASCO Post Staff / Lynn Sage Breast Cancer Symposium 2024

Frederick Howard, MD, on the Role of Targeted Therapy and Endocrine Therapy in the Patient With Breast Cancer

Frederick Howard, MD, discusses the role of targeted therapy and endocrine therapy in the patient with breast cancer, based in part on his presentation at the Lynn Sage Breast Cancer Symposium, Octobe...

Advertisement

Advertisement

Nov

01

Today In Oncology

Quantifying the Benefit of Smoking Cessation Within 6 Months of a Cancer Diagnosis

NCCN Harmonized Guidelines for Sub-Saharan Africa Experts Convene in Ghana to Update Cancer Treatment Guidelines

How End-of-Life Dreams and Visions Are Bringing Comfort to Dying Patients

Inotuzumab Ozogamicin With Low-Intensity Chemotherapy in Older Patients With CD22-Positive Philadelphia Chromosome Negative B-Cell Precursor ALL

DKN-01 With Tislelizumab and Chemotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Advertisement

© 2024 HSP News Service, L.L.C.